24 hour International Mass Spectrometry Imaging (24h-IMSI)
Imaging Mass Spectrometry (IMS) Survey
We’ve created a survey seeking information regarding the use of IMS in different laboratories across the pharmaceutical industry and related academic institutions. The goal is to collate a high-level view of current practices used by industry/academic practitioners to identify areas of commonality or divergence.
The survey is conducted jointly by IMSS and Japan Association for Imaging Mass Spectrometry (JAIMS), an affiliation of Association for Promoting Drug development (APDD, http://www.apdd-jp.org/). This international survey is conducted online using Survey Monkey in both English and Japanese from September 14th through September 25th. The results of this survey will be presented in both English and Japanese during the 24-hour International Mass Spectrometry Imaging (24h-IMSI) Virtual Worldwide Event (http://www.24h-imsi.org/) held on November 18th through November 20th and is then planned to be published in early 2021.
To participate in this survey:
Click here or Scan the QR Code Below
||Click here or Scan the QR Code Below
The Imaging Mass Spectrometry Society (IMSS) is a non-profit organization (501c). Our mission is dedicated to: 1) promoting the development and application of imaging mass spectrometry (IMS) in all applicable venues including academia, government, and industry, 2) enhancing the IMS community by disseminating best practices and acceptance criteria around the IMS methodology, 3) providing continual IMS educational opportunities, and 4) collaborating with other societies that have similar or related goals.